FLAC Annual EBITDA
-$1.37 M
0.00%
31 December 2021
Summary:
As of February 5, 2025, FLAC annual earnings before interest, taxes, depreciation & amortization is -$1.37 millionFLAC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLAC Quarterly EBITDA
-$2.29 M
-$302.80 K-15.21%
30 September 2022
Summary:
As of February 5, 2025, FLAC quarterly earnings before interest, taxes, depreciation & amortization is -$2.29 million, with the most recent change of -$302.80 thousand (-15.21%) on September 30, 2022. Over the past year, it has dropped by -$1.92 million (-521.24%).FLAC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLAC TTM EBITDA
-$5.08 M
-$1.92 M-60.91%
30 September 2022
Summary:
As of February 5, 2025, FLAC TTM earnings before interest, taxes, depreciation & amortization is -$5.08 million, with the most recent change of -$1.92 million (-60.91%) on September 30, 2022. Over the past year, it has dropped by -$4.04 million (-389.14%).FLAC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLAC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -521.2% | -389.1% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
FLAC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | +1696.1% | +3880.9% |
Frazier Lifesciences Acquisition EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$2.29 M(+15.2%) | -$5.08 M(+60.9%) |
| June 2022 | - | -$1.99 M(+477.7%) | -$3.16 M(+114.4%) |
| Mar 2022 | - | -$344.60 K(-24.2%) | -$1.47 M(+7.9%) |
| Dec 2021 | -$1.37 M | -$454.60 K(+23.1%) | -$1.37 M(+31.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$369.20 K(+21.0%) | -$1.04 M(+55.1%) |
| June 2021 | - | -$305.20 K(+28.7%) | -$670.10 K(+83.6%) |
| Mar 2021 | - | -$237.20 K(+85.7%) | -$364.90 K(+185.7%) |
| Dec 2020 | - | -$127.70 K | -$127.70 K |
FAQ
- What is Frazier Lifesciences Acquisition annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Frazier Lifesciences Acquisition?
- What is Frazier Lifesciences Acquisition quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Frazier Lifesciences Acquisition?
- What is Frazier Lifesciences Acquisition quarterly EBITDA year-on-year change?
- What is Frazier Lifesciences Acquisition TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Frazier Lifesciences Acquisition?
- What is Frazier Lifesciences Acquisition TTM EBITDA year-on-year change?
What is Frazier Lifesciences Acquisition annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of FLAC is -$1.37 M
What is the all time high annual EBITDA for Frazier Lifesciences Acquisition?
Frazier Lifesciences Acquisition all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.37 M
What is Frazier Lifesciences Acquisition quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of FLAC is -$2.29 M
What is the all time high quarterly EBITDA for Frazier Lifesciences Acquisition?
Frazier Lifesciences Acquisition all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$127.70 K
What is Frazier Lifesciences Acquisition quarterly EBITDA year-on-year change?
Over the past year, FLAC quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.92 M (-521.24%)
What is Frazier Lifesciences Acquisition TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of FLAC is -$5.08 M
What is the all time high TTM EBITDA for Frazier Lifesciences Acquisition?
Frazier Lifesciences Acquisition all-time high TTM earnings before interest, taxes, depreciation & amortization is -$127.70 K
What is Frazier Lifesciences Acquisition TTM EBITDA year-on-year change?
Over the past year, FLAC TTM earnings before interest, taxes, depreciation & amortization has changed by -$4.04 M (-389.14%)